The profile is currenly unclaimed by the seller. All information is provided by CB Insights.


Other Investors | Alive

About Mitokyne

Mitokyne, founded in 2011, is acquired. It develops small molecule therapeutics to enhance mitochondrial function. The company's small molecule therapeutics help to improve mitochondria function and provide treatment for genetic, metabolic, and neurodegenerative disorders, as well as diseases and conditions of aging. It is based in Cambridge, Massachusetts.

Mitokyne Headquarter Location

1030 Massachusetts Avenue Suite 200

Cambridge, Massachusetts, 02138,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

  • Where is Mitokyne's headquarters?

    Mitokyne's headquarters is located at 1030 Massachusetts Avenue, Cambridge.

  • What is Mitokyne's latest funding round?

    Mitokyne's latest funding round is Other Investors.

  • Who are the investors of Mitokyne?

    Investors of Mitokyne include Longwood Fund.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.